Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Conditions: Motion Sickness, Space; Motion Sickness; Sea Sickness Interventions: Drug: DPI-386 Nasal Gel; Drug: Placebo Nasal Gel Sponsors: Repurposed Therapeutics, Inc.; National Aeronautics and Space Administration (NASA) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Motion Sickness | Research